Metabolic disease risk in children by salivary biomarker analysis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Goodson, J Max ^a   Kantarci, Alpdogan ^a   Hartman, Mor Li ^a   Denis, Gerald V ^b   Stephens, Danielle ^a   Hasturk, Hatice ^a   Yaskell, Tina ^a   Vargas, Jorel ^a   Wang, Xiaoshan ^a   Cugini, Maryann ^a   Barake, Roula ^c   Alsmadi, Osama ^c   Al Mutawa, Sabiha ^d   Ariga, Jitendra ^d   Soparkar, Pramod ^a   Behbehani, Jawad ^e   Behbehani, Kazem ^c   Welty, Francine ^f  

^a FORSYTH INSTITUTE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DASMAN DIABETES INSTITUTE   (Kuwait)

^d MINISTRY OF HEALTH   (Kuwait)

^e KUWAIT UNIVERSITY   (Kuwait)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INSULIN; LEPTIN; AUTACOID;

ARTICLE; BODY WEIGHT; CHILD; FEMALE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; RISK ASSESSMENT; SALIVA ANALYSIS; SALIVA LEVEL; BODY MASS; METABOLIC DISEASES; METABOLISM; RISK; SALIVA;

ADIPONECTIN; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INSULIN; LEPTIN; MALE; METABOLIC DISEASES; RISK; SALIVA;

EID: 84902602930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098799     Document Type: Article

References (44)

1. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, et al. (2007) The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8: 299-306. (Pubitemid 47422902)
2. Groschl M, Rauh M, Wagner R, Neuhuber W, Metzler M, et al. (2001) Identification of leptin in human saliva. JClinEndocrinolMetab 86: 5234-5239. (Pubitemid 33070241)
3. Gupta M, Chaturvedi R, Jain A (2013) Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine 61: 892-897.
4. Gornowicz A, Bielawska A, Bielawski K, Grabowska SZ, Wojcicka A, et al. (2012) Pro-inflammatory cytokines in saliva of adolescents with dental caries disease. Ann Agric Environ Med 19: 711-716.
5. Teles RP, Likhari V, Socransky SS, Haffajee AD (2009) Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 44: 411-417.
6. Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, et al. (2011) Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 38: 434-441.
7. Kang EH, Lee YJ, Hyon JY, Yun PY, Song YW (2011) Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin Exp Rheumatol 29: 970-976.
8. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, et al. (2008) Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis 14: 705-712.
9. Scheicher ME, Teixeira MM, Cunha FQ, Teixeira AL Jr, Filho JT, et al. (2007) Eotaxin-2 in sputum cell culture to evaluate asthma inflammation. Eur Respir J 29: 489-495. (Pubitemid 46372095)
10. Ozcaka O, Nalbantsoy A, Buduneli N (2011) Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 46: 592-598.
11. Marchetti P, Benzi L, Masoni A, Cecchetti P, Giannarelli R, et al. (1986) Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load. Diabetologia 29: 695-698. (Pubitemid 17051038)
12. Aydin S (2007) A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. J Biochem Mol Biol 40: 29-35.
13. Rai B, Kharb S, Jain R, Anand SC (2008) Biomarkers of periodontitis in oral fluids. J Oral Sci 50: 53-56.
14. Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, et al. (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101: 1194-1198.
15. Tenovuo J, Lehtonen OP, Viikari J, Larjava H, Vilja P, et al. (1986) Immunoglobulins and innate antimicrobial factors in whole saliva of patients with insulin-dependent diabetes mellitus. J Dent Res 65: 62-66.
16. Surdacka A, Ciezka E, Piorunska-Stolzmann M, Wender-Ozegowska E, Korybalska K, et al. (2011) Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes. Arch Oral Biol 56: 428-436.
17. Janket SJ, Jones JA, Meurman JH, Baird AE, Van Dyke TE (2008) Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105: 173-179.
18. Groschl M (2009) The physiological role of hormones in saliva. Bioessays 31: 843-852.
19. Al Rashdan I, Al Nesef Y (2009) Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology 61: 42-48.
20. Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, et al. (2006) Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55: 2357-2364. (Pubitemid 44743635)
21. Rosa JS, Heydari S, Oliver SR, Flores RL, Pontello AM, et al. (2011) Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children. J Clin Res Pediatr Endocrinol 3: 115-121.
22. Suriano K, Curran J, Byrne SM, Jones TW, Davis EA (2010) Fatness, Fitness, and Increased Cardiovascular Risk in Young Children. J Pediatr.
23. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, et al. (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109: 45-60. (Pubitemid 34049426)
24. Browne RW, Kantarci A, LaMonte MJ, Andrews CA, Hovey KM, et al. (2013) Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One 8: e59498.
25. CDC (2012) Child and Teen BMI Calculator. Available: http://apps.nccd. cdc.gov/dnpabmi/.
26. Hettmansperger TP, McKean JW (2012) Robust Nonparametric Statistical Methods Second Edition; Bunea F, Isham V, Keiding N, Louis T, Smith RL, et al., editors: CRC Press. Kindle Edition. 520 p.
27. Shea S, Aymong E, Zybert P, Shamoon H, Tracy RP, et al. (2003) Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 11: 95-103. (Pubitemid 41137544)
28. Bagdade JD, Bierman EL, Porte D Jr (1967) The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46: 1549-1557.
29. Kamaryt J, Stejskal J, Mrskos A, Lavicky P (1989) [Insulin, glucose, proteins and amylase in the saliva of obese children]. Cesk Pediatr 44: 517-520.
30. Pasic J, Pickup JC (1988) Salivary insulin in normal and type I diabetic subjects. Diabetes Care 11: 489-494.
31. Marchetti P, Giannarelli R, Masoni A, Cecchetti P, Di Carlo A, et al. (1990) Salivary immunoreactive insulin concentrations are related to plasma free-insulin levels in insulin-treated diabetic patients. Diabete Metab 16: 16-20. (Pubitemid 20119740)
32. Knip M, Nuutinen O (1993) Long-term effects of weight reduction on serum lipids and plasma insulin in obese children. Am J Clin Nutr 57: 490-493. (Pubitemid 23096719)
33. Naidoo T, Konkol K, Biccard B, Dudose K, McKune AJ (2012) Elevated salivary C-reactive protein predicted by low cardio-respiratory fitness and being overweight in African children. Cardiovasc J Afr 23: 501-506.
34. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801. (Pubitemid 44033299)
35. Renaldi O, Pramono B, Sinorita H, Purnomo LB, Asdie RH, et al. (2009) Hypoadiponectinemia: a risk factor for metabolic syndrome. Acta Med Indones 41: 20-24.
36. Lee JY, Chung JW, Kim YK, Chung SC, Kho HS (2007) Comparison of the composition of oral mucosal residual saliva with whole saliva. Oral Dis 13: 550-554.
37. Farb MG, Bigornia S, Mott M, Tanriverdi K, Morin KM, et al. (2011) Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol 58: 232-237.
38. Malamud D (2011) Saliva as a diagnostic fluid. Dent Clin North Am 55: 159-178.
39. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, et al. (2013) B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A 110: 5133-5138.
40. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, et al. (2011) Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 186: 1162-1172.
41. Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, et al. (2009) Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 55: 1530-1538.
42. Rathnayake N, Akerman S, Klinge B, Lundegren N, Jansson H, et al. (2013) Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol 40: 140-147.
43. Kinney JS, Ramseier CA, Giannobile WV (2007) Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 1098: 230-251. (Pubitemid 47092549)
44. Aleksandra Nielsen A, Nederby Nielsen J, Schmedes A, Brandslund I, Hey H (2005) Saliva Interleukin-6 in patients with inflammatory bowel disease. Scand J Gastroenterol 40: 1444-1448. (Pubitemid 43028206)